Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...
Back acne can make anyone feel insecure about exposing their skin. and self-conscious. Back acne is considered a moderately severe form of acne. Like all forms of acne, back acne occurs when the hair ...
SAN MATEO, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and ...
Denifanstat met all endpoints in a Phase 3 acne trial and showed favorable tolerability. Sagimet also launched a Phase 1 trial for TVB-3567. Sagimet Biosciences announced that its oral fatty acid ...
Denifanstat met all primary and secondary endpoints versus placebo and was generally well tolerated in a Phase 3 clinical trial in acne in China conducted by license partner Ascletis Ascletis ...
We all want a flawless, bright-eyed, smooth, clear face. But whether it’s spots, dry skin, flushed cheeks or cracked lips, we ...
Hosted on MSN
Speaking Acne: A Glossary of Common Terms
Acne Vulgaris The medical term for common acne. This acne includes one of more of the following: blackheads, whiteheads, papules (small pimples that don’t contain pus), and pustules (pus-filled ...
Adult acne is more common than often assumed. According to research from the University of Oulu, around 31 per cent of 35-year-old Finnish women have acne on the face or back. Yet many do not ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results